News

The Charles Valentine Riley Memorial Foundation (RMF), in partnership with the American Association for the Advancement of Science (AAAS), is holding its inaugural poster competition for students to ...
Ascletis Pharma Inc. (HKEX: 1672, "Ascletis") announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) agonist ASC30 and adipose-targeted, ...
HONG KONG, June 9, 2025 /PRNewswire/ -- Ascletis Pharma Inc. (HKEX: 1672, 'Ascletis') announces that poster presentations on preliminary studies of its oral small molecule GLP-1 Receptor (GLP-1R) ...
MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that an abstract highlighting pre-clinical data on DA-1241, a ...
MetaVia Announces Poster Presentation on DA-1241 at the ADA's 85th Scientific Sessions Provided by PR Newswire Jun 4, 2025, 5:31:00 AM ...
Median Technologies to Present Scientific Posters on eyonis® LCS in Two Major Health Conferences in North America in May 2025 Provided by Business Wire May 12, 2025, 8:45:00 AM ...
Free Downloadable Scientific Poster Templates Take the stress out of designing your poster with free vertical and horizontal scientific poster templates from Labroots. These Labroots templates are ...
DUBLIN and CHICAGO, April 14, 2025 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM), a company focused on delivering next generation oral and IV antibiotics to treat infections caused by ...
Poster Templates The SOPH Office of Research has developed poster templates for the school’s use. We strongly encourage poster presenters to use these templates. Templates are available for download.
Contribute to JohnClema/Scientific-Poster-Template development by creating an account on GitHub.
LONDON, December 05, 2024--LivaNova PLC today announced its participation in the American Epilepsy Society (AES) 2024 Annual Meeting, taking place Dec. 6-10 in Los Angeles.
In addition, Azafaros will host a satellite symposium on nizubaglustat on Day 2 of the symposium, discussing nizubaglustat’s profile and plans for global Phase 3 studies Six presentations will ...